MDPile
SpecialtyNews
RSS icon
MDPile

  • New Cell Therapy Technology Set to Enter Clinical Trials in 2024

    New Cell Therapy Technology Set to Enter Clinical Trials in 2024

    7/17/2024

  • New Hope for AML Patients: DSP-5336 Receives FDA Fast Track Designation

    New Hope for AML Patients: DSP-5336 Receives FDA Fast Track Designation

    7/15/2024

  • FDA Fast Tracks New Drug for Advanced Leukemia

    FDA Fast Tracks New Drug for Advanced Leukemia

    7/15/2024

  • LLS Invests Millions to Improve Access to Blood Cancer Care

    LLS Invests Millions to Improve Access to Blood Cancer Care

    7/10/2024

  • Moleculin's Promising New AML Treatment Awaits FDA Feedback

    Moleculin's Promising New AML Treatment Awaits FDA Feedback

    7/10/2024

  • New Cancer Drug Olverembatinib Approved for Use in Macau

    New Cancer Drug Olverembatinib Approved for Use in Macau

    7/8/2024

  • Promising Results from Phase I Trial for New Anticoagulant Drug

    Promising Results from Phase I Trial for New Anticoagulant Drug

    7/8/2024

  • Breakthrough in Anticoagulant Treatment: Promising Phase I Results for New RNAi Drug

    Breakthrough in Anticoagulant Treatment: Promising Phase I Results for New RNAi Drug

    7/8/2024

  • New Hope for Follicular Lymphoma: AbbVie’s Epcoritamab Gains Positive Review in Europe

    New Hope for Follicular Lymphoma: AbbVie’s Epcoritamab Gains Positive Review in Europe

    6/28/2024

  • New Hope for Chronic Lymphocytic Leukemia Patients: Advocating for Next-Gen Treatment Inclusion

    New Hope for Chronic Lymphocytic Leukemia Patients: Advocating for Next-Gen Treatment Inclusion

    6/25/2024

  • New Guidelines Aim to Enhance Hemophilia Treatment Protocols

    New Guidelines Aim to Enhance Hemophilia Treatment Protocols

    6/21/2024

  • Breakthrough Treatment CM313 Shows Promising Results for Immune Thrombocytopenia

    Breakthrough Treatment CM313 Shows Promising Results for Immune Thrombocytopenia

    6/20/2024

  • New Hope for Relapsed Multiple Myeloma and AL Amyloidosis Patients with Lisaftoclax

    New Hope for Relapsed Multiple Myeloma and AL Amyloidosis Patients with Lisaftoclax

    6/18/2024

  • Promising Results for Olverembatinib: A New Hope in Treating Resistant Leukemia

    Promising Results for Olverembatinib: A New Hope in Treating Resistant Leukemia

    6/18/2024

  • Breakthrough Therapy for High-Risk Multiple Myeloma Shows Promising Results

    Breakthrough Therapy for High-Risk Multiple Myeloma Shows Promising Results

    6/16/2024

  • New Leaps in Acute Leukemia Treatments: DSP-5336 Shows Promise

    New Leaps in Acute Leukemia Treatments: DSP-5336 Shows Promise

    6/15/2024

  • Groundbreaking Trial Enhances Outcomes for High-Risk Leukemia Patients

    Groundbreaking Trial Enhances Outcomes for High-Risk Leukemia Patients

    6/14/2024

  • Revumenib Shows Promise in Combating Acute Leukemias: Fresh Data from EHA 2024

    Revumenib Shows Promise in Combating Acute Leukemias: Fresh Data from EHA 2024

    6/14/2024

  • New FDA-Approved Device Brings Hope in Emergency Hemorrhage Control

    New FDA-Approved Device Brings Hope in Emergency Hemorrhage Control

    6/13/2024

  • Novel Phone Therapy Boosts Well-Being in Blood Cancer Patients Post-Transplant

    Novel Phone Therapy Boosts Well-Being in Blood Cancer Patients Post-Transplant

    6/11/2024

  • Octapharma's Innovations for Bleeding Disorder Management to Shine at ISTH 2024

    Octapharma's Innovations for Bleeding Disorder Management to Shine at ISTH 2024

    6/10/2024

  • Breakthrough Gene Therapy for Hemophilia A: Long-Term Success of ROCTAVIAN

    Breakthrough Gene Therapy for Hemophilia A: Long-Term Success of ROCTAVIAN

    6/7/2024

  • Blood Cancer Treatment: Phase I Trial of Menin Inhibitor Begins

    Blood Cancer Treatment: Phase I Trial of Menin Inhibitor Begins

    6/7/2024

  • Groundbreaking Advances in Multiple Myeloma Treatment with DARZALEX® Therapy

    Groundbreaking Advances in Multiple Myeloma Treatment with DARZALEX® Therapy

    6/3/2024

  • New Treatment Breakthrough Offers Hope for Relapsed Multiple Myeloma Patients

    New Treatment Breakthrough Offers Hope for Relapsed Multiple Myeloma Patients

    6/2/2024

  • AYVAKIT Shows Promising Results in Treating Rare Blood Disorder

    AYVAKIT Shows Promising Results in Treating Rare Blood Disorder

    5/31/2024

  • FDA Greenlights First Swappable Biosimilar for Rare Blood and Kidney Diseases

    FDA Greenlights First Swappable Biosimilar for Rare Blood and Kidney Diseases

    5/29/2024

  • FDA Paves the Way for New Biosimilar Treatment for Rare Blood Disorders

    FDA Paves the Way for New Biosimilar Treatment for Rare Blood Disorders

    5/28/2024

  • Metformin: A Promising Ally in Reducing Blood Cancer Risk

    Metformin: A Promising Ally in Reducing Blood Cancer Risk

    5/27/2024

  • New Breakthrough in Stem Cell Therapy for Graft vs. Host Disease

    New Breakthrough in Stem Cell Therapy for Graft vs. Host Disease

    5/23/2024

  • New Hope for Elderly Patients with Aggressive Blood Cancer

    New Hope for Elderly Patients with Aggressive Blood Cancer

    5/21/2024

  • AI-Powered Eye Scans Revolutionize Anemia Detection

    AI-Powered Eye Scans Revolutionize Anemia Detection

    5/16/2024

  • New Research Unveils Predictive Factors for Severe Sickle Cell Retinopathy

    New Research Unveils Predictive Factors for Severe Sickle Cell Retinopathy

    5/15/2024

...
0
Terms & Conditions
Privacy Policy
MDPile